Leukocyte Nuclear Appendages, Hereditary Prevalence of

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

The prevalence of stunting, underweight, and wasting did not significantly differ between early-weaned BAN children and matched breastfeeding community children at either 15-16 or 17-18 months of age.

Effect: null; Stunting at 15-16mo: 36% BAN vs 49% community; at 17-18mo: 31% vs 31%. Underweight at 15-16mo: 5% vs 13%; at 17-18mo: 5% vs 3%. Wasting: 0% BAN

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75

Never-recovered borderline patients were about 1.6 times as likely as ever-recovered borderline patients to have multiple poor health-related lifestyle choices including heavy smoking, sedentary behav

Effect: decline; RRR 0.63; CI: 95% CI 0.53, 0.75